APA
Braud V. M., Biton J., Becht E., Knockaert S., Mansuet-Lupo A., Cosson E., Damotte D., Alifano M., Validire P., Anjuère F., Cremer I., Girard N., Gossot D., Seguin-Givelet A., Dieu-Nosjean M. & Germain C.Expression of LLT1 and its receptor CD161 in lung cancer is associated with better clinical outcome. : Oncoimmunology.
Chicago
Braud Véronique M, Biton Jérôme, Becht Etienne, Knockaert Samantha, Mansuet-Lupo Audrey, Cosson Estelle, Damotte Diane, Alifano Marco, Validire Pierre, Anjuère Fabienne, Cremer Isabelle, Girard Nicolas, Gossot Dominique, Seguin-Givelet Agathe, Dieu-Nosjean Marie-Caroline and Germain Claire.Expression of LLT1 and its receptor CD161 in lung cancer is associated with better clinical outcome. : Oncoimmunology.
Harvard
Braud V. M., Biton J., Becht E., Knockaert S., Mansuet-Lupo A., Cosson E., Damotte D., Alifano M., Validire P., Anjuère F., Cremer I., Girard N., Gossot D., Seguin-Givelet A., Dieu-Nosjean M. and Germain C.Expression of LLT1 and its receptor CD161 in lung cancer is associated with better clinical outcome. : Oncoimmunology.
MLA
Braud Véronique M, Biton Jérôme, Becht Etienne, Knockaert Samantha, Mansuet-Lupo Audrey, Cosson Estelle, Damotte Diane, Alifano Marco, Validire Pierre, Anjuère Fabienne, Cremer Isabelle, Girard Nicolas, Gossot Dominique, Seguin-Givelet Agathe, Dieu-Nosjean Marie-Caroline and Germain Claire.: Oncoimmunology. .